WOONSOCKET, R.I. — The Federal Trade Commission (FTC) has closed a two-year investigation into pharmacy benefit management CVS Caremark's business practices, the drug store chain said on Friday. While the FTC made no allegations of antitrust law violations or anti-competitive behavior, the agency alleged from 2007 until at least November 2008, CVS subsidiary Rx America posted incorrect prices for certain Medicare Part D prescription drugs at CVS and Walgreen Co. (WAG) ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.